The utilization of diverse smart devices in the health management of diabetes patients

Xinhao Huang

doi:10.54097/34e2tk57

Authors

Xinhao Huang

DOI:

https://doi.org/10.54097/34e2tk57

Keywords:

Diabetes, Glucose monitoring, Glucose control, Smart devices, Health management.

Abstract

The utilization of smart devices in the management of diabetes has exhibited a significant upward trajectory. These devices aid in preemptively predicting the onset of diabetes, thereby fostering a more convenient and comfortable living environment for patients. However, there is a dearth of comprehensive literature reviews on smart device applications in diabetes management. A comprehensive review was conducted focusing on the utilization of smart devices for monitoring and optimizing diabetes management. The search was centered around relevant keywords including “diabetes”, “monitoring devices”, “self-care”, and “treatment tools”. The search process involved utilizing Web of Science, Google Scholar, and PubMed databases. The present paper examines the implementation of intelligent blood glucose monitoring devices and treatment equipment in diabetes management, encompassing aspects such as principles, usage methods, target populations, and efficacy. The utilization of smart devices in chronic disease healthcare provides significant convenience for patients with diabetes, enabling effective management and prevention of complications. Moreover, the integration of such devices enhances disease management efficacy and improves quality of life in patients.

Downloads

Download data is not yet available.

References

[1] Tobias, D.K., et al., Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine [J]. Nat Med, 2023. 29 (10): p. 2438 - 2457.

[2] Tanase, D.M., et al., The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD) [J]. J Diabetes Res, 2020. 2020: p. 3920196.

[3] Artasensi, A., et al., Type 2 diabetes mellitus: a review of multi-target drugs [J]. Molecules, 2020. 25 (8). 1987.

[4] Zhang, Y., et al., The current state of research on the pathogenesis and therapeutic drugs for diabetic complications [J]. Chinese Pharmacological Bulletin, 2024. 40 (10): p. 1808 - 1813.

[5] Jinghe, H., et al., The objective of this study is to examine the factors influencing the average daily cost of hospitalization in patients diagnosed with type 2 diabetes mellitus, as well as evaluate the economic benefits associated with traditional Chinese medicine treatment [J]. Modern medicine and health, 2023. 39 (14): p. 2407 - 2411.

[6] Sun, H., et al., Erratum to “IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045” [J]. [Diabetes Res. Clin. Pract. 183 (2022) 109119]. Diabetes Research and Clinical Practice, 2023. 183 (204): p. 110945.

[7] Seo, H., et al., Smart contact lenses as wearable ophthalmic devices for disease monitoring and health management [J]. Chem Rev, 2023. 123 (19): p. 11488 - 11558.

[8] Makroum, M.A., et al., Machine learning and smart devices for diabetes management: systematic review [J]. Sensors (Basel), 2022. 22 (5): 1843.

[9] Wei, T., et al., To analyze the accuracy of blood glucose detection by fast blood glucose meter and automatic biochemical analyzer [J]. Chinese Journal of Rural Medicine, 2024. 31 (18): p. 64 - 65.

[10] Pasarica, M., Diabetes: device therapy [J]. FP Essent, 2021. 504: p. 28 - 33.

[11] Heinemann, L., et al., Digital diabetes management: a literature review of smart insulin pens [J]. J Diabetes Sci Technol, 2022. 16 (3): p. 587 - 595.

[12] Grady, M., et al., Real-world evidence of improved glycemic control in people with diabetes using a bluetooth-connected blood glucose meter with a mobile diabetes management app [J]. Diabetes Technol Ther, 2022. 24 (10): p. 770 - 778.

[13] Katz, L.B., et al., Patient satisfaction with a new, high accuracy blood glucose meter that provides personalized guidance, insight, and encouragement [J]. J Diabetes Sci Technol, 2020. 14 (2): p. 318 - 323.

[14] Khan, A.I., et al., The variability of results between point-of-care testing glucose meters and the central laboratory analyzer [J]. Arch Pathol Lab Med, 2006. 130 (10): p. 1527 - 32.

[15] Parkin, C.G., If SMBG accuracy is critical to patient safety, why are inaccurate meters still on the market [J]? J Diabetes Sci Technol, 2017. 11(3): p. 574 - 576.

[16] Shaker G, et al., Peroxidase-coupled glucose method [M]. In: Stat Pearls. Treasure Island (FL): StatPearls Publishing; August 4, 2023.

[17] Uzumer, T.Y., et al., Development of an amperometric biosensor that can determine the amount of glucose in the blood using the glucose oxidase enzyme: Preparation of polyaniline-polypyrrole-poly (sodium-4-styrenesulfonate) film [J]. Biotechnol Appl Biochem, 2024.71 (6): 1440 – 1452.

[18] Abraham, S.B., et al., Improved real-world glycemic control with continuous glucose monitoring system predictive alerts [J]. J Diabetes Sci Technol, 2021. 15 (1): p. 91 - 97.

[19] Polsky, S., et al., Performance of the Dexcom G7 continuous glucose monitoring system in pregnant women with diabetes [J]. Diabetes Technol Ther, 2024. 26 (5): p. 307 - 312.

[20] Garg, S.K., et al., Accuracy and safety of Dexcom G7 continuous glucose monitoring in adults with diabetes [J]. Diabetes Technol Ther, 2022. 24 (6): p. 373 - 380.

[21] Gamarra, E., et al., Continuous glucose monitoring and recreational scuba diving in type 1 diabetes: head-to-head comparison between Free Style Libre 3 and Dexcom G7 performance [J]. Diabetes Technol Ther, 2024. 11 (26): p. 829 - 841.

[22] Oriot, P., et al., Intermittent-scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle-aged adults with type 1 diabetes in real-life setting [J]. J Diabetes Complications, 2023. 37 (2): p. 108385.

[23] Dovc, K., et al., Evolution of diabetes technology [J]. Endocrinol Metab Clin North Am, 2020. 49 (1): p. 1 - 18.

[24] Apablaza, P., N. Soto., et al., Codner, [from insulin pump and continuous glucose monitoring to the artificial pancreas] [J]. Rev Med Chil, 2017. 145 (5): p. 630 - 640.

[25] Nwokolo, M., et al., The artificial pancreas and type 1 diabetes [J]. J Clin Endocrinol Metab, 2023. 108 (7): p. 1614 - 1623.

[26] Hanazaki, K., et al., Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system [J]. J Artif Organs, 2016. 19 (3): p. 209 - 18.

[27] Del, F.S., et al., Randomized summer camp crossover trial in 5- to 9-year-old children: outpatient wearable artificial pancreas is feasible and safe [J]. Diabetes Care, 2016. 39 (7): p. 1180 - 5.

[28] Taylor, M.J., et al., Closed-loop glycaemic control using an implantable artificial pancreas in diabetic domestic pig (Sus scrofa domesticus) [J]. Int J Pharm, 2016. 500 (1-2): p. 371 - 8.

[29] Didangelos, T., et al., Insulin pump therapy in adults [J]. Diabetes Res Clin Pract, 2011. 93 Suppl 1 (11): p. S109 - 13.

[30] Freckmann, G., et al., Insulin pump therapy for patients with type 2 diabetes mellitus: evidence, current barriers, and new technologies [J]. J Diabetes Sci Technol, 2021. 15 (4): p. 901 - 915.

[31] Trema Munno, S., et al., Insulin pump treatment vs. multiple daily insulin injections in patients with poorly controlled Type 2 diabetes mellitus: a comparison of cardiovascular effects [J]. Endocrine, 2024. 84 (1): p. 128 - 135.

[32] Peters, A.L., et al., Diabetic ketoacidosis with canagliflozin, a sodium-glucose cotransporter 2 inhibitor, in patients with type 1 diabetes [J]. Diabetes Care, 2016. 39 (4): p. 532 - 8.

[33] Elsherif, M., et al., Wearable smart contact lenses for continual glucose monitoring: a review [J]. Front Med (Lausanne), 2022. 9: p. 858784.

[34] Najafi, B., et al., An optical-fiber-based smart textile (Smart Socks) to manage biomechanical risk factors associated with diabetic foot amputation [J]. J Diabetes Sci Technol, 2017. 11 (4): p. 668 - 677.

[35] Reyzelman, A.M., et al., An evaluation of real-world smart sock-based temperature monitoring data as a physiological indicator of early diabetic foot injury: case-control study [J]. JMIR Form Res, 2022. 6 (4): p. e31870.

[36] Frykberg, R.G., et al., Feasibility and efficacy of a smart mat technology to predict development of diabetic plantar ulcers [J]. Diabetes Care, 2017. 40 (7): p. 973 - 980.